William John Bush

Filings by William John Bush span 6 companies, the busiest being Stem, Inc., MusclePharm Corp and Findex Com Inc. Over a trading history stretching from 26 June 2006 to 30 April 2024, the count stands at 63 filings.

Market trades split into 9 purchases (€685k) and 19 sales (€3.1M). Sales outweigh purchases by €2.4M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 24 share grants and 10 option exercises. 2024 to date brings no purchases and 4 sales.

In size, the median ticket on the buying side is €2,056. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -4.0%. Past outcomes like these are no guarantee of what comes next.

The latest filing, published on 30 April 2024, reports an option exercise in Stem, Inc. The most recent open-market purchase was published on 10 January 2008, 6,862 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.